A second strike of lightning
The Food and Drug Administration (FDA) approved Vanda/VNDA's, Fanapt, which is an anti-psychotic drug for the treatment of schizophrenia.
The shares now are ~800% higher. Wham! Bam! Pow!
-- David M Gordon / The Deipnosophist
The shares now are ~800% higher. Wham! Bam! Pow!
-- David M Gordon / The Deipnosophist
Labels: Company analyses, Market analyses
posted by David M Gordon | 4:54 AM
<< Home